NCT06135415 2026-03-25
TirbAKare
Almirall, S.A.
Phase 3 Completed
Clinical Trials
12 trialsNCT05741294 2025-02-20
A Study of Tirbanibulin on the Wellbeing of Participants With Actinic Keratoses
Almirall, S.A.
Phase 4 Completed
NCT05060237 2024-10-17
Study to Evaluate Safety and Tolerability of BF-200 ALA (Ameluz®) for Photodynamic Therapy in the Treatment of the Expanded Field of Actinic Keratosis on Face and Scalp
Biofrontera Bioscience GmbH
Phase 1 Completed
NCT05636800 2024-08-06
Microwave Treatment for Actinic Keratosis
Blackwell Device Consulting
Phase NA Active not recruiting
NCT03285477 2021-04-13
AK003
Almirall, S.A.
Phase 3 Completed
NCT03285490 2021-03-10
A Multi-Center Study to Evaluate the Efficacy and Safety of KX2-391 Ointment 1% on Actinic Keratosis on Face or Scalp (AK004)
Almirall, S.A.
Phase 3 Completed
NCT00535080 2021-02-18
Compassionate Use of Metvix® (Methyl Aminolevulinate) Photodynamic Therapy (PDT) in Subjects With Field Actinic Keratoses, Large/Multiple Superficial Basal Cell Carcinomas (BCCs), or Bowen's Disease
Galderma R&D
No longer available
NCT00239135 2015-03-25
Study to Determine the Maximum Tolerated Dose and Safety of PEP005 Topical Gel
Peplin
Phase 2 Completed
NCT00116649 2010-07-20
Open-Label Safety Study to Evaluate Imiquimod Cream, 5% for Large Areas of Actinic Keratosis
Graceway Pharmaceuticals, LLC
Phase 4 Completed
NCT00110682 2008-04-24
Study of Imiquimod 5% Cream in Addition to Cryotherapy in the Management of Actinic Keratoses
Derm Research @ 888 Inc.
Phase 4 Completed
NCT00114023 2007-02-19
1-Year Follow up to the 1473-IMIQ Study
Graceway Pharmaceuticals, LLC
Completed
NCT00115154 2007-02-19
Study to Assess the Safety and Efficacy of Imiquimod 5% Cream for the Treatment of Actinic Keratosis on the Arms and Hands
Graceway Pharmaceuticals, LLC
Phase 4 Completed